This dataset contains the estimated percentage of Californians with asthma (asthma prevalence). Two types of asthma prevalence are included: 1) lifetime asthma prevalence describes the percentage of people who have ever been diagnosed with asthma by a health care provider, 2) current asthma prevalence describes the percentage of people who have ever been diagnosed with asthma by a health care provider AND report they still have asthma and/or had an asthma episode or attack within the past 12 months. The tables “Lifetime Asthma Prevalence by County” and “Current Asthma Prevalence by County” are derived from the California Health Interview Survey (CHIS) and include data stratified by county and age group (all ages, 0-17, 18+, 0-4, 5-17, 18-64, 65+) reported for 2-year periods. The table “Asthma Prevalence, Adults (18 and older)” is derived from the California Behavioral Risk Factor Surveillance System (BRFSS) and includes statewide data on adults reported by year.

The highest prevalence of current asthma among U.S. children was reported in Connecticut, where 10.6 percent of all children were estimated to currently suffer from asthma. This statistic represents the prevalence of current asthma among children in the United States in 2022, by state.

Find data on pediatric asthma in Massachusetts. This dataset provides the number of cases and prevalence of asthma among students, grades K-8, in Massachusetts.

As of 2021, the states with the highest lifetime prevalence of asthma among adults included New Hampshire, Rhode Island, and Vermont. In New Hampshire and Rhode Island around 17.4 percent of adults self-reported that a doctor, nurse, or other health professional had told them that you had asthma at some pinot in their lifetime. Asthma is a chronic disease affecting the airways of the lungs that can be mild or severe and can cause shortness of breath, tightness or pain in the chest, coughing, and wheezing.

The prevalence of asthma in the United States Asthma in the United States is more common among men than women, with around 8.9 percent of women with current asthma in 2021, compared to 6.5 percent of men. Current asthma is also more common among adults than children, with those aged four years and below the least likely age group to suffer from the disease. It is unclear what exactly causes asthma; however it is believed that both environmental and genetic factors play a role. In 2021, non-Hispanic Blacks were more likely to report currently suffering from asthma than their non-Hispanic white and Hispanic counterparts.

Death from asthma Medicine for asthma can help control the disease in the long-term and provide short-term relief from symptoms. Therefore, deaths from asthma in the United States are rare, with it being the underlying cause of death in about one out of every 100,000 population. The states with the highest death rates from asthma are Mississippi, Hawaii, and Oregon. In 2020, there were a total of 4,145 deaths due to asthma in the United States.

This dataset contains year, state and district wise number of Asthma Cases in children of age group 0-5 years

Note: Asthma is a condition in which your airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing) when you breathe out and shortness of breath. For some people, asthma is a minor nuisance.

This web map is part of the Centers for Disease Control and Prevention (CDC) PLACES. It provides model-based estimates of current asthma prevalence among adults aged 18 years and old at county, place, census tract and ZCTA levels in the United States. PLACES is an expansion of the original 500 Cities Project and a collaboration between the CDC, the Robert Wood Johnson Foundation, and the CDC Foundation. Data sources used to generate these estimates include the Behavioral Risk Factor Surveillance System (BRFSS), Census 2020 population counts or Census annual county-level population estimates, and the American Community Survey (ACS) estimates. For detailed methodology see www.cdc.gov/places. For questions or feedback send an email to places@cdc.gov.Measure name used for current asthma is CASTHMA.

The MarketScan health claims database is a compilation of nearly 110 million patient records with information from more than 100 private insurance carriers and large self-insuring companies. Public forms of insurance (i.e., Medicare and Medicaid) are not included, nor are small (< 100 employees) or medium (1000 employees). We excluded the relatively few (n=6735) individuals over 65 years of age because Medicare is the primary insurance of U.S. adults over 65. The EQI was constructed for 2000-2005 for all US counties and is composed of five domains (air, water, built, land, and sociodemographic), each composed of variables to represent the environmental quality of that _domain. Domain-specific EQIs were developed using principal components analysis (PCA) to reduce these variables within each _domain while the overall EQI was constructed from a second PCA from these individual domains (L. C. Messer et al., 2014). To account for differences in environment across rural and urban counties, the overall and _domain-specific EQIs were stratified by rural urban continuum codes (RUCCs) (U.S. Department of Agriculture, 2015). This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Human health data are not available publicly. EQI data are available at: https://edg.epa.gov/data/Public/ORD/NHEERL/EQI. Format: Data are stored as csv files. This dataset is associated with the following publication: Gray, C., D. Lobdell, K. Rappazzo, Y. Jian, J. Jagai, L. Messer, A. Patel, S. Deflorio-Barker, C. Lyttle, J. Solway, and A. Rzhetsky. Associations between environmental quality and adult asthma prevalence in medical claims data. ENVIRONMENTAL RESEARCH. Elsevier B.V., Amsterdam, NETHERLANDS, 166: 529-536, (2018).

Demographic characteristics, lifestyle and clinical features of asthma cases and controls.

In 2022, around 8.2 percent of the U.S. population currently had asthma. Over the past couple decades, the share of the U.S. population with current asthma has fluctuated. The years 2010 and 2011 saw the highest prevalence rates, with 8.5 percent in both years.

Asthma Asthma is a complicated chronic illness that affects a person’s ability to breathe. Symptoms include shortness of breath, wheezing and coughing. Asthma is treatable through avoidance of triggers and through inhaled corticosteroids (an inhaler). Prescriptions of Albuterol, a commonly prescribed inhaler, have increased significantly in the United States. Fortunately, in recent years, the out-of-pocket costs of albuterol have decreased. Asthma among the states The prevalence of asthma in U.S. states varies, with Rhode Island, Maine, and New Hampshire reporting the highest current rates of asthma. However, despite having the highest prevalence rates, these states do not have the highest death rates due to asthma. As of 2021, Mississippi and Hawaii had the highest death rates from asthma in the United States. Among all U.S. residents, the prevalence of active asthma attacks within the past 12 months has decreased over the last few years.

This dataset provides an estimate of the percentage of adult respondents ages 18+ who were ever diagnosed with asthma by a doctor by zip code as well as an estimate of the population ages 18+ residing in that zip code. The estimates covered are from the years 2013-2014. Information like this may be useful for studying asthma rates across zip codes of different demographics.

Spatial Extent: Los Angeles Spatial Unit: Zip Code Created: 2018 Updated: n/a Source: California Health Interview Survey Contact Telephone: 310-794-0909 Contact Email: dacchpr@ucla.edu Source Link: https://askchisne.ucla.edu/ask/_layouts/ne/dashboard.aspx#/API Source Link: https://www.arcgis.com/home/item.html?id=cabe5663e01948dfa4bc31922c2c791b

To create and validate a citywide pediatric Asthma Registry to improve the care and outcomes of children and adolescents in Washington, DC through data-driven quality improvement (QI). All available electronic health record data from inpatient and outpatient domains of Children’s National Hospital were aggregated from an existing enterprise data warehouse. Inclusion criteria included asthma relevant ICD-10 codes over the prior 24 months. Available Asthma Registry measures include patient demographics, ambulatory visits, hospital admissions, persistent asthma diagnoses, and prescription of controller medications. Data capture was validated using US Census data and current asthma prevalence estimate of the Behavioral Risk Factor Surveillance System (BRFSS). The registry identified 15,991 DC children and adolescents with asthma aged 0–17 years, inclusive, at the end of 2020. This was 14.2% higher than the estimate of 14,001 children derived from BRFSS. Characteristics of those in the registry included: mean age of 9.5 (1.4) years, 57.9% male, 72.3% Black, and 66.7% publicly insured. Over the prior 24 months, 30.3% had ≥1 emergency department visit, and 10.5% had ≥1 hospital admission. Controller medications were prescribed for 59.6% of children with persistent asthma. Rates varied by sampled primary care practice sites. A population-level pediatric asthma registry captures more children and adolescents with asthma in DC then a BRFSS-derived estimate, and provides city-wide measures of asthma-related utilization. The registry allows for stratification by primary care practice locations and asthma characteristics, supporting the design, implementation, and evaluation of QI projects at the practice, health system, and population levels. Supplemental data for this article can be accessed at publisher’s website.

As of 2022, the prevalence of current asthma among U.S. children was around six percent. Females had higher rates of asthma than males, with almost 10 percent of females currently suffering from asthma. This statistic represents the current asthma prevalence in the United States in 2022, sorted by gender, age, and race/ethnicity.

This dataset contains counts and rates (per 10,000 residents) of asthma emergency department (ED) visits among Californians. The table “Asthma Emergency Department Visit Rates by County” contains statewide and county-level data stratified by age group (all ages, 0-17, 18+, 0-4, 5-17, 18-64, 65+) and race/ethnicity (white, black, Hispanic, Asian/Pacific Islander, American Indian/Alaskan Native). The table “Asthma Emergency Department Visit Rates by ZIP Code” contains zip-code level data stratified by age group (all ages, 0-17, 18+). The data are derived from the Department of Health Care Access and Information emergency department database. These data include emergency department visits from all licensed hospitals in California. These data are based only on primary discharge diagnosis codes. On October 1, 2015, diagnostic coding for asthma transitioned from ICD9-CM (493) to ICD10-CM (J45). Because of this change, CDPH and CDC do not recommend comparing data from 2015 (or earlier) to 2016 (or later). NOTE: Rates are calculated from the total number of asthma emergency department visits (not the unique number of individuals).

These data contain the Age-Adjusted Colorado Census Tract Rate of Asthma-Related Hospital Discharges (2015-2019) and Inpatient Hospitalizations per 100,000 persons based on the ICD-10 Code of J45-J46. The rates are calculated using the geocoded billing address of discharged individuals found in the dataset with the selected ICD-10 Codes and 2015-2019 Population Estimates from the American Community Survey. These data are from the Colorado Hospital Association's Hospital Discharge Dataset and are published annually by the Colorado Department of Public Health and Environment.

This data shows healthcare utilization for asthma by Allegheny County residents 18 years of age and younger. It counts asthma-related visits to the Emergency Department (ED), hospitalizations, urgent care visits, and asthma controller medication dispensing events.

The asthma data was compiled as part of the Allegheny County Health Department’s Asthma Task Force, which was established in 2018. The Task Force was formed to identify strategies to decrease asthma inpatient and emergency utilization among children (ages 0-18), with special focus on children receiving services funded by Medicaid. Data is being used to improve the understanding of asthma in Allegheny County, and inform the recommended actions of the task force. Data will also be used to evaluate progress toward the goal of reducing asthma-related hospitalization and ED visits.

Regarding this data, asthma is defined using the International Classification of Diseases, Tenth Revision (IDC-10) classification system code J45.xxx. The ICD-10 system is used to classify diagnoses, symptoms, and procedures in the U.S. healthcare system.

Children seeking care for an asthma-related claim in 2017 are represented in the data. Data is compiled by the Health Department from medical claims submitted to three health plans (UPMC, Gateway Health, and Highmark). Claims may also come from people enrolled in Medicaid plans managed by these insurers. The Health Department estimates that 74% of the County’s population aged 0-18 is represented in the data.

Users should be cautious of using administrative claims data as a measure of disease prevalence and interpreting trends over time. Missing from the data are the uninsured, members in participating plans enrolled for less than 90 continuous days in 2017, children with an asthma-related condition that did not file a claim in 2017, and children participating in plans managed by insurers that did not share data with the Health Department.

Data users should also be aware that diagnoses may also be subject to misclassification, and that children with an asthmatic condition may not be diagnosed. It is also possible that some children may be counted more than once in the data if they are enrolled in a plan by more than one participating insurer and file a claim on each policy in the same calendar year.

Support for Health Equity datasets and tools provided by Amazon Web Services (AWS) through their Health Equity Initiative.

This table contains 16896 series, with data for years 1994 - 1998 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia ...), Age group (16 items: Total; 4 years and over; 12 years and over; 12-19 years; 4-11 years ...), Sex (3 items: Both sexes; Females; Males ...), Asthma (4 items: Total population for the variable asthma; Asthma; not stated; With asthma; Without asthma ...), Characteristics (8 items: Number of persons; Low 95% confidence interval - number of persons; High 95% confidence interval - number of persons; Coefficient of variation for number of persons ...).

Objective: To provide updated prevalence estimates of asthma and asthma medication use for women of childbearing age in the United States. Methods: Using data from 11,383 women aged 18–44, including a subset of 1,245 pregnant women, enrolled in the National Health and Nutrition Examination Survey (2001–2016), we assessed the age-adjusted prevalence of self-reported diagnosed asthma. For women aged 18–44, we stratified by year, demographics, and other characteristics. Furthermore, we assessed asthma medication use among women aged 18–44 with asthma. Results: After age-adjustment, 9.9% (95% confidence interval (CI) 9.2%, 10.7%) of women aged 18–44 and 10.9% (95% CI 7.2%, 14.6%) of pregnant women reported having asthma. Asthma prevalence was highest in 2015–2016 (12.0% 95% CI 9.8%, 14.3%) and lowest in 2003–2004 (8.6% 95% CI 6.4%, 10.8%). Women aged 18–44 with Medicaid or State Children’s Health Insurance Program insurance coverage (16.8% 95% CI 14.5%, 19.2%), obesity (14.4% 95% CI 12.9%, 15.8%), diabetes (18.7% 95% CI 12.1%, 25.2%), hypertension (16.6% 95% CI 14.2%, 19.0%), and current smokers (12.8% 95% CI 11.4%, 14.2%) had the highest asthma prevalence. Of women with asthma, 38.3% (95% CI 34.5%, 42.1%) reported using asthma medications in the past 30 days. Conclusions: Among women of childbearing ages, asthma burden varies across demographic and clinical characteristics and has increased in recent years.

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the annual number of hospital discharges, crude hospitalization rates with corresponding 95% confidence intervals, and age-adjusted hospitalization rates (per 10,000 children and adults aged 5 to 64 years) with corresponding 95% confidence intervals, for the years 2000 – 2011, by Chicago U.S. Postal Service ZIP code or ZIP code aggregate. See the full dataset description for more information at http://bit.ly/PKI8p0.

This dataset contains counts and rates (per 1,000,000 residents) of asthma deaths among Californians statewide and by county. The data are stratified by age group (all ages, 0-17, 18+) and reported for 3-year periods. The data are derived from the California Death Statistical Master Files, which contain information collected from death certificates. All deaths with asthma coded as the underlying cause of death (ICD-10 CM J45 or J46) are included.

This dataset tracks the updates made on the dataset "Asthma Prevalence" as a repository for previous versions of the data and metadata.